In addition, one prior clinical trial in patients with seasonal allergic rhinitis demonstrated that the addition of an oral cyclooxygenase-1 inhibitor (naproxyn sodium) to a combination of oral H1-antihistamine plus decongestant (chlorpheniramine plus pseudoephedrine) augmented nasal symptom control significantly [22]. Here, PTGS1 is linked to allergic rhinitis.